trade digital currency searches

Morgan Stanley upgraded the rating of Jingao Technology to over-allocation, with a target price of RMB 27.36. Tongwei shares will be upgraded to overweight with a target price of RMB 39.53.Brazil raised the benchmark lending rate by 100 basis points to 12.25%. Brazil's central bank expects the next two meetings to raise interest rates by the same amount.The rhythm of "Shangxin" accelerates the issuance of public offering REITs exceeding 50 billion yuan during the year. This year, the pace of initial projects in the public offering REITs market has obviously accelerated. Up to now, the cumulative issuance scale during the year has exceeded 50 billion yuan. At the same time, the number of REITs fund managers in the whole market has increased to 25 fund institutions, and the breadth and depth of participation of relevant parties have continued to expand. Looking forward to 2025, institutional sources said that the construction of domestic REITs primary and secondary markets is expected to continue to advance. With the entry of more diversified assets and investor types, the market scale and activity are expected to further increase. (Economic Information Daily)

Goldman Sachs upgraded Societe Generale to neutral. Chris Hallam, an analyst at Goldman Sachs, had a previous rating of sell. The target price is 29.25 euros, which is 9% higher.The offshore RMB (CNH) was quoted at 7.2791 yuan against the US dollar at 05:59 Beijing time, down 212 points from late new york on Tuesday, and traded in the range of 7.2425-7.2921 yuan in the whole day. After the A-share market closed, there was a rapid decline.Market News: The United Nations General Assembly adopted a resolution by an overwhelming majority, demanding an immediate and unconditional permanent ceasefire in the Gaza Strip.

The onshore RMB closed at 7.2615 yuan against the US dollar at night, down 124 points from Tuesday's night closing. The turnover was $57.609 billion.Bank of Brazil: The Committee has been paying close attention to how recent financial developments affect monetary policy and financial assets.GF Securities maintained the "Buy" rating of Giant Bio with a reasonable value of HK$ 55.72.